Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

MSF is calling for increased scale-up of "viral load" HIV treatment monitoring in order to help improve people’s HIV treatment outcomes.

More >

As trade ministers negotiating the TPP convene in Singapore this weekend for high-level talks aimed at securing a deal by the end of the year, MSF warns that the vital lifeline of affordable medicines that millions depend on could be severely constrained by the pact's terms.

More >

MSF responds to the Global Fund's annoucement that it had received pledges totalling $12 billion for the next three years, falling short of its minimum target of $15 billion.

More >

This week, MSF warned the Global Fund of the consequences of a new pricing intitative that could result in middle-income countries paying higher prices for medicines.

More >

In several countries where MSF works—such DRC, Guinea, Central African Republic, Nigeria, South Sudan and Myanmar—timely treatment remains out of reach for the majority of people who need it.

More >

As TPP negotiators gather to meet for the first time since the intellectual property chapter of the secret trade agreement was leaked last week, MSF is urging countries to stand strongly against the US government’s attack on access to affordable medicines.

More >

PARIS/NEW YORK—Without a new approach to developing and pricing new tuberculosis (TB) medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis (DR-TB), warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the Union World Conference on Lung Health in Paris.

More >

Several key policy changes are urgently needed at the GAVI Alliance to help reach the 22.6 million children not benefitting from vaccination globally.

More >

This continued ‘fatal imbalance’ in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.

More >